Life science news 13 July 2026: Vertex seals a $10 billion deal for rare endocrine specialist Crinetics, the FDA clears the first dual BAFF/APRIL inhibitor for IgA nephropathy, and Novartis acquires a UK cancer therapy spinout in a blockbuster week for pharma, biotech...
The current news cycle is dominated by new and exotic-sounding organisms and chemicals: PFOS, bisphenols, phthalates, Mpox, New World screwworm, Andes hantavirus, Ebola bundibugyo, Borrelia burgdorferi, dengue, and chikungunya. What do they have in common? They are...
Life science news 6 July 2026: the FDA expands the world’s first CRISPR gene therapy to children as young as two, Ipsen commits up to $1.75 billion for a late-stage blood cancer drug, and two first-in-class FDA approvals reshape the cell therapy landscape in a busy...
Last year it was Joe Biden and Barnaby Joyce who made public their diagnoses of prostate cancer. Before them, came other household names battling this condition – from Ben Stiller to Rod Stewart. This admission, on Jeremy Clarkson’s own TV show for his need of...
Working in healthcare tends to very much not be about self-care, and yet healthcare self-care has never mattered more. It’s about caring for others, prioritising the needs of the many over yourself, and responding both physically and emotionally whilst managing an...
Life science news 29 June 2026: AbbVie and Merck KGaA announce blockbuster acquisitions totalling more than $22 billion, NICE recommends the first disease-modifying therapy for type 1 diabetes for NHS use, and Definium Therapeutics delivers a landmark Phase 3 result...
Phacilitate announces the return of Advanced Therapies Week (ATW) for its 22nd year, reinforcing its status as one of the most established and influential cell and gene therapy (CGT) conferences in the United States and among the most recognized globally. In...
New research published (22 January 2026) in The Lancet Psychiatry warn that lessons have not been learned from the pandemic when it comes to mental health. The researchers recommend that mental health should be treated as a core consideration when it comes to pandemic...
Thousands of men in England with advanced prostate cancer are set to gain access to a new life extending treatment following a decision by the National Institute for Health and Care Excellence. The move marks a significant development in the management of one of the...
Oxford Biomedica has officially confirmed it is in preliminary discussions with the Swedish private equity giant EQT regarding a potential cash takeover. The announcement follows significant market speculation and a sharp rise in the company’s share price on January...
In a move that signals a significant shift in the global pharmaceutical supply chain landscape, Thermo Fisher Scientific (NYSE: TMO) has announced a substantial influx of new contracts within its pharmaceutical services business. The common thread among these new...
Press Release: Patients to benefit sooner as UK boosts clinical trials attractiveness with faster assessments and agile regulation The MHRA is now setting out the next phase of reforms for 2026, aimed at helping patients access new cutting-edge treatments more...
The dream is always the same: strike out on your own and build something that’s truly yours. Perhaps you’re spinning out from a university, commercialising years of research with a fellow academic who shares your vision. Or maybe you’re breaking away from the big...
Leaders in life sciences and nuclear urge review of proposed changes Leaders across the science sector have made an urgent call to government to reconsider potentially harmful reforms to the way apprenticeships are assessed. Members of two leading employer bodies...
Dhruv Shenai explores how females have been left behind in conversations on autism by discussing the history and lack of female representation within the field. Neuroscientist Gina Rippon has spent years challenging the male-centred bias in autism research. Her new...
The U.S. Food and Drug Administration released its official list of novel drug approvals for 2025, marking a year of significant therapeutic breadth and scientific innovation. Novel drugs are defined as new molecular entities or biologics approved for use in the...
The life sciences industry is advancing at a speed that would have felt unimaginable just a few years ago. Artificial intelligence is shortening drug discovery timelines. Digital therapeutics are reshaping care delivery. Precision medicine is moving healthcare from...
As 2026 begins, it is natural to pause and reflect on the year behind us while thinking about what lies ahead. In the life sciences, these reflections often centre on progress: new experiments to launch, collaborations to build, technologies to adopt, or ideas to...